Alamri et al. used genetically engineered mice carrying Brca1 and Trp53 mutations to explore how CRC methodology compared to his- torical methods of mammary epithelial cell isolation for initial primary cell isolation, allograft generation, and impact of CRC and passage on the transcriptome [65]. The gene discussed is BRCA1; the disease is colorectal carcinoma.